{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2023"],"data_sharing_plan":["IPD Sharing (as of October 2023): Undecided\nDescription: Undecided"],"condition":["Colorectal Cancer","Colorectal Neoplasms","Breast Cancer"],"disease":["Colorectal Cancer","Colorectal Neoplasms","Breast Cancer"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/108259"],"location":["United States"],"study_start_month":["6"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Tumor-Derived FGF19","description":"Identify and test thresholds, specificity and sensitivity for a potential cancer associated biomarker protein, FGF19, (and associated markers) for detection in human blood in the blood of breast and colorectal in cancer patients, and see if occurs at higher rates than healthy controls","dates":{"creation":"2023-06-15"},"accession":"108259","cross_references":{"ClinicalTrials___gov":["NCT06068257"]}}